Scisparc
Price & Volume
Stats
See more52W Range | $1.75-$24.36 |
Market Cap | $3.9M |
Shares Short | 73,189 |
Financials
See moreRevenue (12 Mos) | $1.3M |
Revenue Growth (YoY) | -45.1% |
Gross Profit (12 Mos) | $506,000 |
Diluted EPS | -$22.65 |
News
See moreYahoo Finance • 9 days ago
Clearmind Medicine Files Israeli Patent for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression
Yahoo Finance • 27 days ago
N2OFF Completed Merger with Cancer Drug Discovery Company Targeting Tough-to-Treat Pancreatic and Lung Cancers
Yahoo Finance • last month
SciSparc Announces Closing of the Acquisition of a Publicly Traded Company on the TSXV to which it transferred its Advanced Clinical Stage Pharmaceutical Portfolio
Yahoo Finance • last month
Clearmind Medicine Announces Publication of U.S. Patent Application Targeting Binge Behavior Disorders
About
CEO | Mr. Oz Adler CPA |
CFO | Mr. Oz Adler CPA |
Address | Tower A, Tel Aviv, Israel, 6971916 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 2 |
